Control of Allergic Rhinitis and Asthma Test (CARAT): dissemination and applications in primary care

Pedro Azevedo, Jaime Correia de Sousa, Jean Bousquet, António Bugalho-Almeida, Stefano R Del Giacco, Pascal Demoly, Tari Haahtela, Tiago Jacinto, Vanessa Garcia-Larsen, Thys van der Molen, Mário Morais-Almeida, Luis Nogueira-Silva, Ana M Pereira, Miguel Román Rodríguez, Bárbara G Silva, Ioanna G Tsiligianni, Hakan Yaman, Barbara Yawn, João A Fonseca, WHO Collaborative Center for Asthma and Rhinitis, Montpellier, Pedro Azevedo, Jaime Correia de Sousa, Jean Bousquet, António Bugalho-Almeida, Stefano R Del Giacco, Pascal Demoly, Tari Haahtela, Tiago Jacinto, Vanessa Garcia-Larsen, Thys van der Molen, Mário Morais-Almeida, Luis Nogueira-Silva, Ana M Pereira, Miguel Román Rodríguez, Bárbara G Silva, Ioanna G Tsiligianni, Hakan Yaman, Barbara Yawn, João A Fonseca, WHO Collaborative Center for Asthma and Rhinitis, Montpellier

Abstract

Asthma frequently occurs in association with allergic rhinitis and a combined management approach has been suggested. The Control of Allergic Rhinitis and Asthma Test (CARAT) is the first questionnaire to assess control of both diseases concurrently. However, to have an impact on healthcare it needs to be disseminated and adopted. In this paper we discuss the dissemination of CARAT in different countries and its possible applications in primary care. At present, the adaptation of CARAT for use in different languages and cultures is being led by volunteer researchers and clinicians in 15 countries. Website and smartphone applications have been developed, and a free open model of distribution was adopted to contribute to the dissemination of CARAT. Examples of dissemination activities include distribution of leaflets and posters, educational sessions on the use of the questionnaire in the follow-up of patients, development of clinical studies, collaborations with professional organisations and health authorities, and the inclusion of CARAT in clinical guidelines. The adoption of innovations is an important challenge in healthcare today, and research on the degree of success of dissemination strategies using suitable methods and metrics is much needed. We propose that CARAT can be used in a range of settings and circumstances in primary care for clinical, research and audit purposes, within the overall aim of increasing awareness of the level of disease control and strengthening the partnership between patients and doctors in the management of asthma and rhinitis.

Conflict of interest statement

The authors declare that they have no conflicts of interest in relation to this article.

Figures

Figure 1
Figure 1
CARAT use case scenarios

References

    1. Wenzel S. Asthma: defining of the persistent adult phenotypes. Lancet 2006;368(9537):804–13.
    1. Cruz AA, Popov T, Pawankar R, et al. ARIA Initiative Scientific Committee. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy 2007;62(Suppl 84):1–41.
    1. Bousquet J, Schünemann HJ, Zuberbier T, et al. Development and implementation of guidelines in allergic rhinitis — an ARIA-GA2LEN paper. Allergy 2010;65(10):1212–21.
    1. Price D, Zhang Q, Kocevar VS, Yin DD, Thomas M. Effect of a concomitant diagnosis of allergic rhinitis on asthma-related healthcare use by adults. Clin Exp Allergy 2005;35(3):282–7.
    1. Costa DJ, Bousquet PJ, Ryan D, et al. Guidelines for allergic rhinitis need to be used in primary care. Prim Care Respir J 2009;18(4):250–7.
    1. Andrade CR, Cunha Ibiapina C, Gonçalves AC, Fernandes FMJ, Lima BLM, Moreira PA. Asthma and allergic rhinitis co-morbidity: a cross-sectional questionnaire study on adolescents aged 13–14 years. Prim Care Respir J 2008;17(4):222–5.
    1. Holgate S, Bjermer L, Haahtela T, et al. The Brussels Declaration: the need for change in asthma management. Eur Respir J 2008;32(6):1433–42.
    1. Pinnock H, Fletcher M, Holmes S, et al. Setting the standard for routine asthma consultations: a discussion of the aims, process and outcomes of reviewing people with asthma in primary care. Prim Care Respir J 2010;19(1)75–83.
    1. Nogueira-Silva L, Martins SV, Cruz-Correia R, et al. Control of allergic rhinitis and asthma test: a formal approach to the development of a measuring tool. Respir Res 2009;10:52.
    1. Fonseca JA, Nogueira-Silva L, Morais-Almeida M, et al. Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma. Allergy 2010;65(8):1042–8.
    1. Fonseca JA, Nogueira-Silva L, Morais-Almeida M, et al. Control of Allergic Rhinitis and Asthma Test (CARAT) can be used to assess individual patients over time. Clin Transl Allergy 2012;2(1):16.
    1. Mokkink LB, Terwee CB, Knol DL, et al. The COSMIN checklist for evaluating the methodological quality of studies on measurement properties: a clarification of its content. BMC Med Res Methodol 2010;10:22.
    1. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004;113(1):59–65.
    1. Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14:902–07.
    1. Demoly P, Jankowski R, Chassany O, Bessah Y, Allaert FA. Validation of a self-questionnaire for assessing the control of allergic rhinitis. Clin Exp Allergy 2011;41(6):860–8.
    1. Schatz M, Meltzer EO, Nathan R, et al. Psychometric validation of the Rhinitis Control Assessment Test: a brief patient-completed instrument for evaluating rhinitis symptom control. Ann Allergy Asthma Immunol 2010;104(2):118–24.
    1. Baiardini I, Pasquali M, Giardini A, et al. Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. Allergy 2003;58(4):289–94.
    1. Pinnock H, Thomas M, Tsiligianni I, et al. The International Primary Care Respiratory Group (IPCRG) Research Needs Statement 2010. Prim Care Respir J 2010;19(Suppl 1):S1–20.
    1. Pinnock H, Østrem A, Rodriguez MR, et al. Prioritising the respiratory research needs of primary care: the International Primary Care Respiratory Group (IPCRG) e-Delphi exercise. Prim Care Respir J 2012;21(1):19–27.
    1. Lenfant C. Clinical research to clinical practice — lost in translation? N Engl J Med 2003;349:868–74.
    1. Owen N, Glanz K, Sallis JF, Kelder SH. Evidence-based approaches to dissemination and diffusion of physical activity interventions. Am J Prev Med 2006;31(4 Suppl):S35–44.
    1. Wild D, Grove A, Martin M, et al; ISPOR Task Force for Translation and Cultural Adaptation. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 2005;8(2):94–104.
    1. Braido F, Bousquet PJ, Brzoza Z, et al. Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and/or asthma: a GA(2)LEN taskforce position paper. Allergy 2010;65:959–68; Annex III 953.
    1. Tomlins R. International Primary Care Respiratory Group (IPCRG) guidelines: dissemination and implementation — a proposed course of action. Prim Care Respir J 2006;15(1)71–4.
    1. Burnay E, Jacinto T, Sa-Sousa A, Cruz-Correia R, Fonseca J. Challenges of a mobile application for asthma and allergic rhinitis patient enablement — interface and synchronization. Telemed e-Health 2013. (in press).

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit